{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=TARE", "query": { "intervention": "TARE" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 21, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=TARE&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-11T21:14:47.228Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04339036", "title": "CapTemY90 for Grade 2/3 NET Liver Metastases", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Neuroendocrine Tumor Grade 2", "Neuroendocrine Tumors" ], "interventions": [ { "name": "Capecitabine Oral Product", "type": "DRUG" }, { "name": "Temozolomide Oral Product", "type": "DRUG" }, { "name": "transarterial radioembolization", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "DRUG", "COMBINATION_PRODUCT" ], "sponsor": "Abramson Cancer Center at Penn Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 70, "start_date": "2021-10-07", "completion_date": "2028-07-01", "has_results": false, "last_update_posted_date": "2026-06-04", "last_synced_at": "2026-09-11T21:14:47.228Z", "location_count": 4, "location_summary": "La Jolla, California • Miami, Florida • Buffalo, New York + 1 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Buffalo", "state": "New York" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04339036" }, { "nct_id": "NCT04720209", "title": "Taking AIM at Breast Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Breast Cancer", "Breast Cancer Stage I", "Breast Cancer Stage II", "Breast Cancer Stage III" ], "interventions": [ { "name": "CARE", "type": "OTHER" }, { "name": "TARE", "type": "OTHER" }, { "name": "Home-Based Stretching", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Dana-Farber Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 102, "start_date": "2021-08-13", "completion_date": "2026-09-15", "has_results": false, "last_update_posted_date": "2025-09-23", "last_synced_at": "2026-09-11T21:14:47.228Z", "location_count": 2, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04720209" }, { "nct_id": "NCT05537402", "title": "LOcoregional vs Systemic Therapy in Patients With BCLC Stage B HCC", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hepatocellular Carcinoma" ], "interventions": [ { "name": "Atezolizumab and bevacizumab", "type": "DRUG" }, { "name": "transarterial chemoembolization (TACE) or transarterial radioembolization (TARE", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "RADIATION" ], "sponsor": "University of Texas Southwestern Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1, "start_date": "2023-09-27", "completion_date": "2025-06-06", "has_results": true, "last_update_posted_date": "2026-06-18", "last_synced_at": "2026-09-11T21:14:47.228Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05537402" }, { "nct_id": "NCT07586046", "title": "Defining the Ablative Dose for Y-90 TARE", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "HCC - Hepatocellular Carcinoma" ], "interventions": [ { "name": "Yttrium-90 Radiation Segmentectomy (Y90 RS) using glass microspheres", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2026-05", "completion_date": "2029-05", "has_results": false, "last_update_posted_date": "2026-05-14", "last_synced_at": "2026-09-11T21:14:47.228Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT07586046" }, { "nct_id": "NCT06860815", "title": "Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Anatomic Stage IV Breast Cancer AJCC v8", "Metastatic Breast Carcinoma", "Metastatic Carcinoma in the Liver" ], "interventions": [ { "name": "Biopsy", "type": "PROCEDURE" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Cemiplimab", "type": "BIOLOGICAL" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Transarterial Radioembolization", "type": "RADIATION" }, { "name": "Yttrium Y 90 Resin Microspheres", "type": "RADIATION" } ], "intervention_types": [ "PROCEDURE", "BIOLOGICAL", "RADIATION" ], "sponsor": "City of Hope Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 11, "start_date": "2026-01-30", "completion_date": "2027-01-30", "has_results": false, "last_update_posted_date": "2026-05-20", "last_synced_at": "2026-09-11T21:14:47.228Z", "location_count": 1, "location_summary": "Duarte, California", "locations": [ { "city": "Duarte", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06860815" }, { "nct_id": "NCT07145801", "title": "Y-90 Treatment Response Using Transarterial Radioembolization", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "HCC", "Hepatocellular Carcinoma", "Liver Cancer", "Hepatic Neoplasm", "Primary Liver Cancer", "Liver Neoplasm" ], "interventions": [ { "name": "Lumason", "type": "DIAGNOSTIC_TEST" }, { "name": "Sonazoid", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Thomas Jefferson University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2025-09-11", "completion_date": "2027-06-30", "has_results": false, "last_update_posted_date": "2026-06-10", "last_synced_at": "2026-09-11T21:14:47.228Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT07145801" }, { "nct_id": "NCT06627244", "title": "Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Metastatic Uveal Melanoma", "Metastatic Uveal Melanoma in the Liver" ], "interventions": [ { "name": "Tebentafusp", "type": "DRUG" }, { "name": "TheraSphere™ Yttrium-90 Trans-Arterial Radioembolization", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "RADIATION" ], "sponsor": "University of Miami", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2025-02-14", "completion_date": "2031-02-17", "has_results": false, "last_update_posted_date": "2026-02-23", "last_synced_at": "2026-09-11T21:14:47.228Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06627244" }, { "nct_id": "NCT02558205", "title": "Correlation Between CT Perfusion and Post Y-90 TARE PET/CT Dosimetry", "overall_status": "WITHDRAWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Hepatocellular Carcinoma" ], "interventions": [ { "name": "CT Liver Perfusion", "type": "RADIATION" }, { "name": "PET/CT of liver", "type": "RADIATION" } ], "intervention_types": [ "RADIATION" ], "sponsor": "Rush University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2015-07", "completion_date": "2020-07", "has_results": false, "last_update_posted_date": "2020-10-08", "last_synced_at": "2026-09-11T21:14:47.228Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02558205" }, { "nct_id": "NCT03900845", "title": "Adherence and Perspiration While Wearing Lower Limb Prostheses", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Lower Extremity Amputation" ], "interventions": [ { "name": "Dynamic Air Exchange - Rising Edge Design (DAE-RED)", "type": "DEVICE" }, { "name": "Perforated elastomeric liner", "type": "DEVICE" }, { "name": "As-prescribed prosthesis", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Seattle Institute for Biomedical and Clinical Research", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 20, "start_date": "2019-02-17", "completion_date": "2022-06-28", "has_results": true, "last_update_posted_date": "2026-01-27", "last_synced_at": "2026-09-11T21:14:47.228Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT03900845" }, { "nct_id": "NCT04315883", "title": "Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Hepatoblastoma", "Hepatocellular Carcinoma", "Rhabdoid Tumor of Liver", "Undifferentiated (Embryonal) Sarcoma of the Liver", "Pediatric Liver Cancer", "Liver Tumors" ], "interventions": [ { "name": "Quality of Life Assessment", "type": "BEHAVIORAL" }, { "name": "Transarterial Radioembolization", "type": "RADIATION" } ], "intervention_types": [ "BEHAVIORAL", "RADIATION" ], "sponsor": "Nemours Children's Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "0 Years", "maximum_age": "21 Years", "sex": "ALL", "summary": "0 Years to 21 Years" }, "enrollment_count": 3, "start_date": "2021-02-11", "completion_date": "2024-03-28", "has_results": false, "last_update_posted_date": "2024-06-12", "last_synced_at": "2026-09-11T21:14:47.228Z", "location_count": 2, "location_summary": "Wilmington, Delaware • Jacksonville, Florida", "locations": [ { "city": "Wilmington", "state": "Delaware" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04315883" } ] }